Hepatocyte SREBP signaling mediates clock communication within the liver
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
应用场景：
创建时间：
2023-07-20
相关数据集
DOM FIGURE 5 Gene expression of Prkaa1 and Prkaa2 is increased by substrate challenge in hepatocytes from vehicle treated mice ex vivo and by chronic treatment with AZD1656 (3mg/kg) for 8 wk.
mRNA levels for Prkaa1 (AMPK-alpha1) and Prkaa2 (AMPK-alpha2) were determined in the experiments described in Fig. 4 in hepatocytes isolated from mice treated for 8-weeks with vehicle or AZD1656 (1 or
DataCite Commons2020-06-25 更新80
Liver X receptor controls a bifurcated transcriptional program where lipogenesis genes overshoot upon refeeding while cholesterol biosynthesis genes return to pre-fasting levels [lxr_chip]
Transitions from a fed to a fasted state are common in mammals. The liver orchestrates adaptive responses to feeding/fasting by transcriptionally regulating metabolic pathways of energy usage and stor
NIAID Data Ecosystem20
Liver transcriptome analysis of lean mice expressing a SUMO-deficient Prox1 (K556R) mutant in hepatocytes. Liver transcriptome analysis of lean mice expressing a SUMO-deficient Prox1 (K556R) mutant in hepatocytes
Accumulation of excess nutrients hampers proper liver function and is linked to non-alcoholic fatty liver disease (NAFLD) in obesity. However, the signals responsible for an impaired adaptation of hep
NIAID Data Ecosystem10
Transcription profiling by array of liver tissues from mice with liver-specific knockout of Pit1 and wild-type littermates fed with either a high-fat diet or chow control diet
The liver plays a central role in whole-body lipid and glucose homeostasis. Increasing dietary fat intake results in increased hepatic fat deposition, which is associated with a risk for development o
Alliance of Genome Resources20
Phosphoproteomics-directed manipulation reveals SEC22B as an hepatocellular signaling node governing metabolic actions of glucagon
The peptide hormone glucagon is a fundamental metabolic regulator that is also being considered as a pharmocotherapeutic option for obesity and type 2 diabetes. Despite this, we know very little of ho
NIAID Data Ecosystem10
